drugset / Trial / NCT04665453

Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children

NCT04665453

Completed 150 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The aim of the study is to compare the effect of melatonin, given orally, dexmedetomidine, given intranasally, and dexmedetomidine given sublingually on sleep induction, sleep duration, their possible impact on vital functions and technical implementation of EEG.

Timeline

Start
2020-09-01
Primary completion
2022-09-01
Completion
2022-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 3 ug/kg Other
Subject Dexmedetomidine Other / unclassified 3 ug/kg Intranasal
Subject Melatonin Small molecule 0.1 mg/kg Oral

Indications